news
Aimovig approved by EU for migraine prevention
Researchers found that more than one quarter (26 per cent) of patients taking Aimovig 70mg were migraine free after month 15...
List view / Grid view
migraine
news
FDA approves Aimovig as a preventive treatment for migraines
The FDA has approved Aimovig for the preventive treatment of a migraine in adults. The treatment is given by once-monthly self-injections...
news
Ketamine may help treat migraine pain unresponsive to other therapies
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain...
news
Cannabinoids suitable for migraine prevention
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
news
Novartis to globally co-commercialise Amgen’s migraine drug
27 April 2017 | By Niamh Marriott, Junior Editor
Novartis has expanded their commercialisation agreement with Amgen for AMG 334 (erenumab), which is being investigated for the prevention of migraine...
news
Eli Lilly to aquire pain biotech CoLucid for $960 million
19 January 2017 | By Niamh Marriott, Digital Editor
This transaction will be acting to enhance Lilly's existing portfolio in pain management for migraine, while adding a potential near-term launch...
news
AMG 334 significantly reduces monthly migraine days in study
9 June 2016 | By Victoria White, Digital Content Producer
Novartis has announced positive first results from a Phase II investigating the efficacy and safety of AMG 334 (erenumab) in chronic migraine prevention...
